tiprankstipranks
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
US Market
ARWR
Arrowhead Pharmaceuticals
RESEARCH TOOLSreports
Want to see ARWR full AI Analyst Report?

Arrowhead Pharmaceuticals (ARWR) Income Statement

1,681 Followers

Arrowhead Pharmaceuticals Income Statement

Last quarter (Q2 2026), Arrowhead Pharmaceuticals's total revenue was $73.74M, a decrease of -86.41% from the same quarter last year. In Q2, Arrowhead Pharmaceuticals's net income was $-132.73M. See Arrowhead Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
$ 829.45M$ 3.55M$ 240.74M$ 243.23M$ 138.29M
Gross Profit
$ 829.45M$ -15.04M$ 228.24M$ 232.81M$ 0.00
Operating Expenses
$ 731.10M$ 586.04M$ 433.24M$ 411.32M$ 279.06M
Depreciation and Amortization
$ 23.93M$ 18.59M$ 12.49M$ 10.42M$ 8.27M
EBITDA
$ 164.82M$ -561.51M$ -175.67M$ -162.29M$ -132.58M
Operating Income
$ 98.35M$ -601.08M$ -205.00M$ -178.51M$ -149.04M
Other Income/Expenses
$ -46.81M$ -11.38M$ -1.49M$ 5.80M$ 8.19M
Pretax Income
$ 51.53M$ -612.46M$ -206.49M$ -172.71M$ -140.85M
Net Income
$ -1.63M$ -599.49M$ -205.28M$ -176.06M$ -140.85M
Per Share Metrics
Basic EPS
$ -0.01$ -5.00$ -1.91$ -1.67$ -1.36
Diluted EPS
$ -0.01$ -5.00$ -1.92$ -1.67$ -1.36
Weighted Average Shares Outstanding
 133.76M 119.78M 107.31M 105.43M 103.75M
Weighted Average Shares Outstanding (Diluted)
 133.76M 119.78M 106.75M 105.43M 103.75M
Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History